PubMed · 2006 · 76 citations · 5 references
MedicineHematologyOncologyChemotherapyGastrointestinal OncologyHematologic OncologyGastrointestinal NeoplasmsMalignant NeoplasmsMultiple MyelomaGastrointestinal MalignancyHigh-dose Chemotherapy AdministrationMultiple Myeloma ChemotherapyMultiple Myeloma TherapyMultiple Myeloma TreatmentMyeloma Pathogenesis
We report 24 cases of multiple myeloma (MM) with involvement of the gastrointestinal (GI) system. We found a strong association with high A lactate dehydrogenase levels, plasmablastic morphology, and A unfavorable karyotype. GI involvement at the time of initial diagnosis was much rarer than later in the course of the disease. The A median survival after diagnosis of GI involvement was 7 months. Among 13 patients treated with stem cell transplantation, the response rate was 92%, and median progression-free survival was 4 months. We conclude that MM involving the GI system is associated with adverse biological features and with short-lasting remissions, even after A high-dose chemotherapy.
5
Cytogenetic findings in 200 patients with multiple myeloma
Jeffrey R. Sawyer, James A. Waldron, Sundar Jagannath et al. · Cancer Genetics and Cytogenetics · 1995 · 357 citations
Medicine, Hematology, Oncology +14
Histologic classification and staging of multiple myeloma
Reiner Bartl · Hematological Oncology · 1988 · 91 citations